本页面由Tiger Trade Technology Pte. Ltd.提供服务

Psyence Biomedical Ltd

1.76
-0.0500-2.76%
盘后1.770.0100+0.57%19:50 EST
成交量:6.19万
成交额:11.09万
市值:328.63万
市盈率:-0.32
高:1.85
开:1.81
低:1.76
收:1.81
52周最高:62.72
52周最低:1.41
股本:186.72万
流通股本:185.98万
量比:0.30
换手率:3.33%
股息:- -
股息率:- -
每股收益(TTM):-5.5651
每股收益(LYR):5.24
净资产收益率:-74.29%
总资产收益率:-34.44%
市净率:0.28
市盈率(LYR):0.34

数据加载中...

2024/08/27

SEC问询函

Form CORRESP - Correspondence
2024/08/20

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/07/31

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/07/27

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/05/13

SEC问询函

Form CORRESP - Correspondence
2024/05/10

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/09

SEC问询函

Form CORRESP - Correspondence
2024/05/07

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/06

SEC问询函

Form CORRESP - Correspondence
2024/04/18

SEC问询函

Form CORRESP - Correspondence
2024/04/18

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/02/10

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/02/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/01/31

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/01/23

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/01/17

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/11/15

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/11/13

SEC问询函

Form CORRESP - Correspondence
2023/11/03

SEC问询函

Form CORRESP - Correspondence